🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,385

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

1,328 results for “China” Clear

  1. Vincristine Sulfate Liposome

    China SXT Pharmaceuticals

    Adult Acute Lymphoblastic Leukemia

    phase 3 small molecule active

    1 trial

  2. Wumeiwan Jiawei Fang

    China SXT Pharmaceuticals

    Dry Eye Syndromes

    phase 3 small molecule active

    1 trial

  3. Xiang-Sha-Liu-Jun-Zi-Tang

    China SXT Pharmaceuticals

    Irritable Bowel Syndrome

    phase 3 small molecule active

    1 trial

  4. YiQiFang

    China SXT Pharmaceuticals

    Cancer

    phase 3 small molecule completed

    2 trials

  5. Yinhu Qingwen Granula

    China SXT Pharmaceuticals

    COVID-19

    phase 3 small molecule on hold

    1 trial

  6. a compound glutamine capsule

    China SXT Pharmaceuticals

    Mucositis

    phase 3 small molecule active

    1 trial

  7. a compound glutamine capsule/a compound glutamine capsule simulated placebo

    China SXT Pharmaceuticals

    Mucositis

    phase 3 small molecule active

    1 trial

  8. a patient self-reporting applet

    China SXT Pharmaceuticals

    Cancer Pain

    phase 3 other active

    1 trial

  9. administering RASI (the trade name or universal name will not be stipulated) before stenting

    China SXT Pharmaceuticals

    Carotid Stenosis

    phase 3 small molecule active

    1 trial

  10. avatrombopag

    China SXT Pharmaceuticals

    Thrombocytopenia

    phase 3 small molecule active

    1 trial

  11. behavior intervention and male circumcision

    China SXT Pharmaceuticals

    HIV

    phase 3 other active

    1 trial

  12. bevacizumab

    China SXT Pharmaceuticals

    Disease Free Survival

    phase 3 small molecule active

    1 trial

  13. cART(TDF/AZT+3TC+LPV/r)

    China SXT Pharmaceuticals

    Acute HIV Infection

    phase 3 small molecule active

    1 trial

  14. chemotherapy and SHR-1316(Adebrelimab) comnined with surgery or radiotherapy

    China SXT Pharmaceuticals

    Limited Stage Small Cell Lung Cancer

    phase 3 other active

    1 trial

  15. cisplatin

    China SXT Pharmaceuticals

    Oral Cavity

    phase 3 small molecule completed

    1 trial

  16. cisplatin i.p.

    China SXT Pharmaceuticals

    Epithelial Carcinoma, Ovarian

    phase 3 small molecule active

    1 trial

  17. clopidogrel and aspirin

    China SXT Pharmaceuticals

    Atherosclerosis

    phase 3 small molecule active

    1 trial

  18. daclatasvir

    China SXT Pharmaceuticals

    Hepatitis C

    phase 3 small molecule completed

    1 trial

  19. desiccated thyroid extract (DTE)+levothyroxine (L-T4)

    China SXT Pharmaceuticals

    Intermediate-to-High Risk Differentiated Thyroid Cancer

    phase 3 small molecule active

    1 trial

  20. folic acid

    China SXT Pharmaceuticals

    Colorectal Neoplasms

    phase 3 small molecule active

    1 trial

  21. gemcitabine and cisplatin (Induction chemotherapy)

    China SXT Pharmaceuticals

    Nasopharyngeal Carcinoma

    phase 3 small molecule active

    1 trial

  22. gemcitabine and cisplatin; docetaxel, cisplatin and fluorouracil

    China SXT Pharmaceuticals

    Nasopharyngeal Carcinoma

    phase 3 small molecule active

    1 trial

  23. gemcitabine,nimotuzumab, toripalimab

    China SXT Pharmaceuticals

    Nasopharyngeal Carcinoma

    phase 3 small molecule active

    1 trial

  24. glutamine combined with thalidomide

    China SXT Pharmaceuticals

    Mucositis Oral

    phase 3 small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources